As a privately held business, Hippocratic AI is not now listed on any stock exchanges, such as the NASDAQ or NYSE. Since Hippocratic AI is a privately held business, Hippocratic AI stock price is not publicly available. However, you can use Forge Data to access the Hippocratic AI private market stock price.

Since Hippocratic AI is not presently a publicly traded corporation, it does not have an official ticker symbol. Forge, one of the largest private market trading platforms, assists institutional investors in finding liquidity when they purchase and sell private shares for their clients or portfolios. 

Forge private market experts have worked with institutional corporations for decades.

To avoid AI detection, use Undetectable AI. It can do it in a single click.

Hippocratic AI

Hippocratic AI is a language model for patient-facing healthcare applications that aims to solve the global shortage of healthcare personnel by developing Health General Intelligence (HGI) with a safety focus.

The organization’s goal is to increase access to healthcare and boost the effectiveness of medical personnel while maintaining evidence-based practice and putting patient safety foremost. Founded in 2022 by Alex Miller, Munjal Shah, and Vishal Parikh, Hippocratic AI is based in San Francisco, California.

Hippocratic AI Stock Price

Hippocratic AI stock price can be computed by dividing the company’s valuation by the total number of outstanding shares. We do not know what number of shares are in circulation right now because a private corporation can issue new shares at any time.

Assuming, however, that Hippocratic AI has issued 250 million shares, each share of Hippocratic AI stock would be worth $2.16 at the estimated UpMarket valuation of $539.45 million.

Hippocratic AI Funding

$137 million has been raised by Hippocratic AI.

Hippocratic AI Investors

Of the 13 investors who have made investments in Hippocratic AI, five are 7wireVentures, Greycroft, Memorial Hermann Foundation, nVentures, and OhioHealth.

Hippocratic AI Competitors

Hippocratic AI has 53 competitors, including Kyruus, Lumeon, Glooko, Athenahealth, and TigerConnect.

Hippocratic AI Valuation and Revenue

Over five rounds, Hippocratic AI has raised $135 million. On September 19, 2024, Hippocratic AI raised $17 million in its recent fundraising round, a Series A-II. In March 2024, Hippocratic AI was valued at $500 million.

Hippocratic AI Deal Terms

The deal structure for Hippocratic AI, which includes their Series A from March 18, 2024, is eligible for one funding round.

How to Buy Hippocratic AI Stock?

You have to be eligible to invest as an accredited investor before you can use Forge to invest in a private firm such as Hippocratic AI.

• To use Forge’s marketplace, register for a free account.
• Show that you are interested in certain investments. You might discover comprehensive price and financing details for thousands of private businesses in Forge Markets.
• A dedicated Forge Private Market Specialist can be on hand during this process to answer any queries you might have and to help you move smoothly through each stage of the transaction.

Not everyone can buy Hippocratic AI stock because it is not publicly traded. You need to be an accredited investor in order to purchase stock in private companies such as Hippocratic AI.

You can sign up for Forge’s Secondary Marketplace to purchase private market stock if you fulfill the accreditation requirements. Learn how to begin and become eligible for new investment opportunities if you are not accredited.

How to Sell Hippocratic AI Stock?

Forge can assist you with selling any Hippocratic AI private business shares you might have, whether you were an early investor or an employee.

• Register for a free Forge account to acquire access to the marketplace and speak with a knowledgeable Private Market Specialist about any queries you may have.
• Use Forge platform to express interest in selling your Hippocratic AI.
• Collaborate with your committed Private Market Specialist, who can help you in navigating the entire process.

You have the option to sell your existing Hippocratic AI stock. Forge can assist you with selling your shares in a way that suits both your needs and the interests of the business. To begin the process, register with Forge right now if you are searching for liquidity.

If you have any questions along the road, a dedicated Forge Private Market Specialist can be on hand to answer them.

How Hippocratic AI Pre-IPO Trades Operate?

Accredited investors tend to buy shares from existing owners through specialist investment platforms such as UpMarket in pre-IPO trades for Hippocratic AI. Hippocratic AI does not issue new shares or accept funds; instead, shares are privately swapped between two parties. Trades often take place on the secondary market.

Although investors hope to make money from a possible IPO or acquisition, these investments are risky because of the lack of information and liquidity. Since each transaction might include different terms and conditions, it is necessary to understand them thoroughly.

Investing in private businesses carries a high risk of substantial capital loss.

When Hippocratic AI Becomes Public?

The choice of becoming public through an IPO is a complicated one that is influenced by a number of variables, such as the company’s financial performance, the state of the market, and its strategic objectives. 

Any forecasts regarding when or whether Hippocratic AI would become public would be hypothetical until the company officially announces its intention to do so. For any updates on possible IPO plans, investors interested in Hippocratic AI should keep an eye on the company’s official communications and trustworthy financial news sources.

Conclusion: Hippocratic AI Stock

In order to enable founders, staff, and investors to participate in equity ownership, Hippocratic AI and almost every privately held businesses issue shares. However, compared to a publicly traded firm, it is difficult to purchase shares of Hippocratic AI due to its private ownership.

The founders, management, staff, venture capital funds, and other private people and institutional investors own shares of Hippocratic AI because it is a privately held firm.

Since private and public firms are subject to different disclosure laws, it might not always be possible to determine the complete ownership of a private company such as Hippocratic AI.

FAQs: Hippocratic AI Stock

What is Hippocratic AI and what do they do?

Hippocratic AI is a company focused on using artificial intelligence to improve healthcare outcomes. Their mission is to create generative AI solutions that assist healthcare professionals in delivering better patient care.

By using a large language model (LLM), Hippocratic AI aims to enhance the efficiency and accuracy of medical diagnoses and treatments while prioritizing patient safety.

How is the Hippocratic AI stock performing currently?

The performance of Hippocratic AI stock is contingent on various factors, including market trends, investor sentiment, and the company’s financial health. Since Hippocratic AI is currently a privately held entity, there is not a publicly available stock price.

Investors interested in Hippocratic AI should keep an eye on their funding rounds and any potential plans for an IPO in the future.

What are the recent funding rounds for Hippocratic AI?

Hippocratic AI has successfully completed a series A funding round, raising significant capital to advance their generative AI technologies. Notable investors in this round include firms such as Andreessen Horowitz and General Catalyst, which have shown confidence in the company’s vision and potential in the digital health sector.

Who are the primary Hippocratic AI investors?

The primary Hippocratic AI investors include prominent venture capital firms such as Andreessen Horowitz, General Catalyst, and other notable players in the tech and healthcare sectors. These investors recognize the potential of Hippocratic AI’s innovative approaches to healthcare and artificial intelligence.

Can I buy Hippocratic AI stock?

You cannot buy Hippocratic AI stock as the company is still privately held. However, interested investors can look for opportunities to invest in future funding rounds or consider other companies in the healthcare AI space that are publicly traded.